EP4061369A4 - Forme pharmaceutique comprenant une substance acide - Google Patents

Forme pharmaceutique comprenant une substance acide Download PDF

Info

Publication number
EP4061369A4
EP4061369A4 EP20889151.5A EP20889151A EP4061369A4 EP 4061369 A4 EP4061369 A4 EP 4061369A4 EP 20889151 A EP20889151 A EP 20889151A EP 4061369 A4 EP4061369 A4 EP 4061369A4
Authority
EP
European Patent Office
Prior art keywords
acidic substance
pharmaceutical form
pharmaceutical
acidic
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20889151.5A
Other languages
German (de)
English (en)
Other versions
EP4061369A1 (fr
Inventor
Fatih Sunel
Gulcin TOK
Selin KOKSAL UZUN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2019/18013A external-priority patent/TR201918013A2/tr
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP4061369A1 publication Critical patent/EP4061369A1/fr
Publication of EP4061369A4 publication Critical patent/EP4061369A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
EP20889151.5A 2019-11-19 2020-10-27 Forme pharmaceutique comprenant une substance acide Pending EP4061369A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TR2019/18013A TR201918013A2 (tr) 2019-11-19 2019-11-19 Propi̇veri̇n veya propi̇veri̇ni̇n farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzunu i̇çeren pellet kompozi̇syonu
TR2020/16210A TR202016210A2 (tr) 2019-11-19 2020-10-12 Asidik madde içeren farmasötik form
PCT/TR2020/051001 WO2021101483A1 (fr) 2019-11-19 2020-10-27 Forme pharmaceutique comprenant une substance acide

Publications (2)

Publication Number Publication Date
EP4061369A1 EP4061369A1 (fr) 2022-09-28
EP4061369A4 true EP4061369A4 (fr) 2024-04-10

Family

ID=75980705

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20889151.5A Pending EP4061369A4 (fr) 2019-11-19 2020-10-27 Forme pharmaceutique comprenant une substance acide

Country Status (3)

Country Link
EP (1) EP4061369A4 (fr)
CA (1) CA3162409A1 (fr)
WO (1) WO2021101483A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100596276C (zh) * 2005-01-26 2010-03-31 杭州民生药业有限公司 长春西汀缓释胶囊及其制备方法
CN102579404A (zh) * 2012-01-17 2012-07-18 广州科的信医药技术有限公司 一种盐酸丙哌维林缓释胶囊及其制备方法
CN103417544A (zh) * 2012-05-22 2013-12-04 欣凯医药化工中间体（上海）有限公司 甲氨叶酸复方制剂及其制备方法和用途
CN104546782A (zh) * 2014-10-30 2015-04-29 南京科康生物科技有限公司 一种硫辛酸肠溶微丸制剂及其制备方法
EP2588090B1 (fr) * 2010-07-01 2017-04-19 KRKA, tovarna zdravil, d.d., Novo mesto Formes pharmaceutiques posologiques orales comprenant de l'étéxilate de dabigatran et ses sels pharmaceutiquement acceptables

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10149674A1 (de) * 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
ITMI20061024A1 (it) 2006-05-25 2007-11-26 Eurand Pharmaceuticals Ltd Pellet a base di acido lipoico

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100596276C (zh) * 2005-01-26 2010-03-31 杭州民生药业有限公司 长春西汀缓释胶囊及其制备方法
EP2588090B1 (fr) * 2010-07-01 2017-04-19 KRKA, tovarna zdravil, d.d., Novo mesto Formes pharmaceutiques posologiques orales comprenant de l'étéxilate de dabigatran et ses sels pharmaceutiquement acceptables
CN102579404A (zh) * 2012-01-17 2012-07-18 广州科的信医药技术有限公司 一种盐酸丙哌维林缓释胶囊及其制备方法
CN103417544A (zh) * 2012-05-22 2013-12-04 欣凯医药化工中间体（上海）有限公司 甲氨叶酸复方制剂及其制备方法和用途
CN104546782A (zh) * 2014-10-30 2015-04-29 南京科康生物科技有限公司 一种硫辛酸肠溶微丸制剂及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021101483A1 *

Also Published As

Publication number Publication date
WO2021101483A1 (fr) 2021-05-27
EP4061369A1 (fr) 2022-09-28
CA3162409A1 (fr) 2021-05-27

Similar Documents

Publication Publication Date Title
GB201911928D0 (en) Pharmaceutical compounds
GB201911944D0 (en) Pharmaceutical compounds
IL290447A (en) Pharmaeutical composition comprising ensifentrine
GB201915273D0 (en) Pharmaceutical compounds
GB201914910D0 (en) Pharmaceutical compounds
PL4003293T3 (pl) Rozwój farmaceutyczny
GB201915932D0 (en) Pharmaceutical compounds
IL289619A (en) A pharmaceutical preparation containing a tetrahydropyrazolopyrimidine compound
GB201901989D0 (en) Pharmaceutical combinations
EP4062938A4 (fr) Association médicamenteuse
EP3890703B8 (fr) Nouvelle formulation pharmaceutique comprenant un modulateur du sting
IL291570A (en) Pharmaceutical preparations
EP3723761A4 (fr) Forme pharmaceutique orale solide comprenant de la linagliptine
GB201906473D0 (en) Pharmaceutical formulation
EP4061369A4 (fr) Forme pharmaceutique comprenant une substance acide
IL289927A (en) A new pharmaceutical formulation
EP4074313A4 (fr) Préparation pharmaceutique solide
HUE064434T2 (hu) Gyógyászati készítmény
EP3737563A4 (fr) Déplacement d'une substance
HK40077614A (en) Pharmaceutical compounds
HK40076183A (en) Pharmaceutical compounds
HK40068990A (en) Pharmaceutical compounds
SG10201912063PA (en) A pharmaceutical formulation
HK40034195A (en) Pharmaceutical compounds
HK40023105B (en) A pharmaceutical formulation comprising psilocybin

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220517

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

A4 Supplementary search report drawn up and despatched

Effective date: 20240311

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/22 20060101ALI20240304BHEP

Ipc: A61K 9/20 20060101ALI20240304BHEP

Ipc: A61K 9/16 20060101ALI20240304BHEP

Ipc: A61K 9/50 20060101ALI20240304BHEP

Ipc: A61K 47/38 20060101ALI20240304BHEP

Ipc: A61P 13/10 20060101ALI20240304BHEP

Ipc: A61P 13/00 20060101ALI20240304BHEP

Ipc: A61K 31/445 20060101AFI20240304BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET A.S.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250320